Literature DB >> 10711634

A new technique for implantation of tissue culture melanoma cells in a murine model of metastatic ocular melanoma.

S Dithmar1, D Rusciano, H E Grossniklaus.   

Abstract

The aim of this study was to compare the transcorneal and transconjunctival techniques for the implantation of intraocular melanoma cells and development of metastasis in a murine model. Groups of C57BL/6 mice were given either transconjunctival or transcorneal inoculations of 2.5 x 10(5)/2.5 microl tissue culture B16-LS9 melanoma cells into the intraocular posterior compartment (PC). The eyes were enucleated at 4-11 days post-inoculation and histologically examined. The mice were sacrificed 14 days after enucleation and necropsies were performed with histological evaluation for visceral metastases. Intraocular and extraocular tumour growth was present in all of the eyes inoculated via the transconjunctival route. Pulmonary metastases were found in this group if the eye was enucleated 7 or more days post-inoculation. The melanoma remained confined to the inside of the eye in the transcorneal group until day 7. Haematogenous metastases to the lung and liver developed from the intraocular melanoma in this group. Transcorneal inoculation of tissue culture melanoma cells into the murine PC provides a useful animal model for visceral metastasis of ocular melanoma.

Entities:  

Mesh:

Year:  2000        PMID: 10711634

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  20 in total

1.  Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma.

Authors:  Lei Dong; Shuo You; Qing Zhang; Satoru Osuka; Narra S Devi; Stefan Kaluz; Jalisa H Ferguson; Hua Yang; Guoliang Chen; Binghe Wang; Hans E Grossniklaus; Erwin G Van Meir
Journal:  Clin Cancer Res       Date:  2018-12-18       Impact factor: 12.531

2.  Constitutive overexpression of pigment epithelium-derived factor inhibition of ocular melanoma growth and metastasis.

Authors:  Hua Yang; Hans E Grossniklaus
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-06       Impact factor: 4.799

3.  Host pigment epithelium-derived factor (PEDF) prevents progression of liver metastasis in a mouse model of uveal melanoma.

Authors:  John M Lattier; Hua Yang; Susan Crawford; Hans E Grossniklaus
Journal:  Clin Exp Metastasis       Date:  2013-06-22       Impact factor: 5.150

Review 4.  Animal Eye Models for Uveal Melanoma.

Authors:  Jinfeng Cao; Martine J Jager
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

Review 5.  Uveal Melanoma Metastasis Models.

Authors:  Hua Yang; Jinfeng Cao; Hans E Grossniklaus
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

6.  Dipyrimidine amines: a novel class of chemokine receptor type 4 antagonists with high specificity.

Authors:  Aizhi Zhu; Weiqiang Zhan; Zhongxing Liang; Younghyoun Yoon; Hua Yang; Hans E Grossniklaus; Jianguo Xu; Mauricio Rojas; Mark Lockwood; James P Snyder; Dennis C Liotta; Hyunsuk Shim
Journal:  J Med Chem       Date:  2010-11-24       Impact factor: 7.446

7.  Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma.

Authors:  Hua Yang; Martine J Jager; Hans E Grossniklaus
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-20       Impact factor: 4.799

8.  Modeling the behavior of uveal melanoma in the liver.

Authors:  Robert Folberg; Lu Leach; Klara Valyi-Nagy; Amy Y Lin; Marsha A Apushkin; Zhuming Ai; Vivian Barak; Dibyen Majumdar; Jacob Pe'er; Andrew J Maniotis
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-07       Impact factor: 4.799

9.  In-vivo xenograft murine human uveal melanoma model develops hepatic micrometastases.

Authors:  Hua Yang; Guofu Fang; Xinping Huang; Jie Yu; Chia-Ling Hsieh; Hans E Grossniklaus
Journal:  Melanoma Res       Date:  2008-04       Impact factor: 3.599

10.  Inhibition of a vascular ocular tumor growth by IL-12 gene transfer.

Authors:  Adriana Albini; Gianfranco Fassina; Massimo Nicolò; Raffaella Dell'Eva; Roberta Vené; Rosaria Cammarota; Massimo Barberis; Douglas M Noonan
Journal:  Clin Exp Metastasis       Date:  2007-07-25       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.